SCNI vs UTHR · P/E 0.2, rev $1.3M vs P/E 20, rev $1.56B
Scinai Immunotherapeutics Ltd (SCNI) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
SCNI currently screens at market cap $1.8M and trailing P/E 0.2. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the SCNI and UTHR stock pages for the full models.
Not investment advice.